This work demonstrates how nature-inspired and derived approaches can significantly impact energy storage. Also, it provides a workflow to accelerate the development of these technologies, helping these batteries move closer to market readiness.
Pioneering work in bioelectrochemistry, particularly the employing of yeast cells to generate electrical current, had substantially favored the comprehension of bioelectrochemical reactions. This foundational research has boosted the development of bioelectrochemical systems (BES), which are significant for sustainable energy solutions. BES technologies, such as biobatteries, biosupercapacitors, and enzymatic and microbial biofuel cells, harness organic and biological systems to provide environmentally-friendly alternatives for energy storage and conversion. Despite their potential, these technologies face challenges in achieving competitive energy densities and long-term stability compared to traditional accumulators and converters. Here, we introduce a new Ragone plot for BES, highlight the pathways to overcome key challenges, and compare BES with traditional technologies. A roadmap outlining future directions for BES development is also presented.
The COVID-19 pandemic has highlighted the critical need for scalable, rapid, and cost-effective diagnostic solutions, especially in resource-limited settings. In this study, we developed a sustainable magnetic electrochemical biosensor for the mass testing of SARS-CoV-2, emphasizing affordability, environmental impact reduction, and clinical applicability. By leveraging recycled materials from spent batteries and plastics, we achieved a circular economy-based fabrication process with a recyclability rate of 98.5%. The biosensor employs MnFe2O4 nanoparticles functionalized with anti-SARS-CoV-2 antibodies, integrated into a 3D-printed electrochemical device for decentralized testing. Advanced characterization confirmed the biosensor's robust performance, including high sensitivity (LOD: 3.46 pg mL-1) and specificity, with results demonstrating a 95% correlation to RT-PCR gold standard testing. The cost of materials used per biosensor test is only USD 0.2, making it highly affordable and suitable for large-scale production using additive manufacturing. Key features include simple preparation, rapid response, and reusability, making it ideal for point-of-care diagnostics. Beyond COVID-19, this platform's modularity allows for adaptation to other viral diseases, offering a versatile solution to global diagnostic challenges. This work highlights the potential of integrating electrochemical sensing with sustainable practices to address healthcare inequities and reduce environmental impact.
23 July 2024 in ACS Sustainable Chemistry & Engineering